Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Single- and double-hit events in genes encoding immune targets before and after T cell–engaging antibody therapy in MM

Blood Adv (2021) 5 (19): 3794–3798.

https://doi.org/10.1182/bloodadvances.2021004418

Published: 2021

Includes: Supplemental data

Journal Articles

Preclinical evaluation of immunotherapeutic regimens for fetal/neonatal alloimmune thrombocytopenia

Huiying Zhi, Maria T. Ahlen, Björn Skogen, Debra K. Newman, Peter J. Newman

Blood Adv (2021) 5 (18): 3552–3562.

https://doi.org/10.1182/bloodadvances.2021004371

Published: 2021

Includes: Supplemental data

Journal Articles

Effective anti-BCMA retreatment in multiple myeloma

Nicolas Gazeau, David Beauvais, Ibrahim Yakoub-Agha, Suman Mitra, Timothy B. Campbell, Thierry Facon, Salomon Manier

Blood Adv (2021) 5 (15): 3016–3020.

https://doi.org/10.1182/bloodadvances.2021004176

Published: 2021

Journal Articles

Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions

Sarah J. Waldis, Stacey Uter, Donna Kavitsky, Cynthia Flickinger, Sunitha Vege, David F. Friedman, Connie M. Westhoff, Stella T. Chou

Blood Adv (2021) 5 (3): 737–744.

https://doi.org/10.1182/bloodadvances.2020003732

Published: 2021

Includes: Supplemental data

Journal Articles

Teclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma

Kodandaram Pillarisetti, Gordon Powers, Leopoldo Luistro, Alexander Babich, Eric Baldwin, Yingzhe Li, Xiaochun Zhang, Mark Mendonça, Nate Majewski, Rupesh Nanjunda, Diana Chin, Kathryn Packman, Yusri Elsayed, Ricardo Attar, François Gaudet

Blood Adv (2020) 4 (18): 4538–4549.

https://doi.org/10.1182/bloodadvances.2020002393

Published: 2020

Includes: Supplemental data

Journal Articles

A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data

Ti-Cheng Chang, Kelly M. Haupfear, Jing Yu, Evadnie Rampersaud, Vivien A. Sheehan, Jonathan M. Flanagan, Jane S. Hankins, Mitchell J. Weiss, Gang Wu, Sunitha Vege, Connie M. Westhoff, Stella T. Chou, Yan Zheng

Blood Adv (2020) 4 (18): 4347–4357.

https://doi.org/10.1182/bloodadvances.2020002148

Published: 2020

Includes: Supplemental data

Journal Articles

Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant

Pingping Zheng, John Tamaresis, Govindarajan Thangavelu, Liwen Xu, Xiaoqing You, Bruce R. Blazar, Robert S. Negrin, James L. Zehnder, Bettina P. Iliopoulou, Everett H. Meyer

Blood Adv (2020) 4 (17): 4232–4243.

https://doi.org/10.1182/bloodadvances.2019000977

Published: 2020

Includes: Supplemental data

Journal Articles

von Willebrand factor variant D1472H has no effect in mice with humanized VWF-platelet interactions

Hannah K. Lohmeier, Tricia L. Slobodianuk, Sachiko Kanaji, Sandra L. Haberichter, Robert R. Montgomery, Veronica H. Flood

Blood Adv (2020) 4 (17): 4065–4068.

https://doi.org/10.1182/bloodadvances.2020002629

Published: 2020

Journal Articles

Predictive modeling of complex ABO glycan phenotypes by lectin microarrays

Waseem Q. Anani, Heather E. Ashwood, Anna Schmidt, Robert T. Burns, Gregory A. Denomme, Karin M. Hoffmeister

Blood Adv (2020) 4 (16): 3960–3970.

https://doi.org/10.1182/bloodadvances.2020002051

Published: 2020

Includes: Supplemental data

Journal Articles

Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease

Alexander Ngwube, Niketa Shah, Kamar Godder, David Jacobsohn, Monica L. Hulbert, Shalini Shenoy

Blood Adv (2020) 4 (16): 3894–3899.

https://doi.org/10.1182/bloodadvances.2020002236

Published: 2020

Journal Articles

Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies

Blood Adv (2020) 4 (15): 3776–3787.

https://doi.org/10.1182/bloodadvances.2020002509

Published: 2020

Includes: Supplemental data

Journal Articles

Development and validation of a universal blood donor genotyping platform: a multinational prospective study

Blood Adv (2020) 4 (15): 3495–3506.

https://doi.org/10.1182/bloodadvances.2020001894

Published: 2020

Includes: Supplemental data

Journal Articles

Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D′D3 and D4 domains

Monica Sacco, Stefano Lancellotti, Mattia Ferrarese, Francesco Bernardi, Mirko Pinotti, Maira Tardugno, Erica De Candia, Leonardo Di Gennaro, Maria Basso, Betti Giusti, Massimiliano Papi, Giordano Perini, Giancarlo Castaman, Raimondo De Cristofaro

Blood Adv (2020) 4 (14): 3405–3415.

https://doi.org/10.1182/bloodadvances.2020002334

Published: 2020

Includes: Supplemental data

Journal Articles

Low VWF: insights into pathogenesis, diagnosis, and clinical management

James S. O’Donnell

Blood Adv (2020) 4 (13): 3191–3199.

https://doi.org/10.1182/bloodadvances.2020002038

Published: 2020

Journal Articles

CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma

Poornima Ramkumar, Anthony B. Abarientos, Ruilin Tian, Meghan Seyler, Jaime T. Leong, Merissa Chen, Priya Choudhry, Torsten Hechler, Nina Shah, Sandy W. Wong, Thomas G. Martin, III, Jeffrey L. Wolf, Kole T. Roybal, Andreas Pahl, Jack Taunton, Arun P. Wiita, Martin Kampmann

Blood Adv (2020) 4 (13): 2899–2911.

https://doi.org/10.1182/bloodadvances.2019001346

Published: 2020

Includes: Supplemental data

Journal Articles

Passively transferred IgG enhances humoral immunity to a red blood cell alloantigen in mice

David R. Gruber, Amanda L. Richards, Heather L. Howie, Ariel M. Hay, Jenna N. Lebedev, Xiaohong Wang, James C. Zimring, Krystalyn E. Hudson

Blood Adv (2020) 4 (7): 1526–1537.

https://doi.org/10.1182/bloodadvances.2019001299

Published: 2020

Includes: Supplemental data

Journal Articles

Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial

Richard T. Maziarz, Stephen J. Schuster, Vadim V. Romanov, Elisha S. Rusch, Junlong Li, James E. Signorovitch, David G. Maloney, Frederick L. Locke

Blood Adv (2020) 4 (7): 1440–1447.

https://doi.org/10.1182/bloodadvances.2019001305

Published: 2020

Includes: Supplemental data

Journal Articles

Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire

Nabila Belhouachi, Aliki Xochelli, Myriam Boudjoghra, Claude Lesty, Nathalie Cassoux, Christine Fardeau, Thi Ha Chau Tran, Sylvain Choquet, Bishnu Sarker, Caroline Houillier, Agusti Alentorn, Phuc LeHoang, Carole Soussain, Valerie Touitou, Helene Merle-Beral, Khe Hoang-Xuan, Bahram Bodaghi, Kostas Stamatopoulos, Frederic Davi

Blood Adv (2020) 4 (7): 1357–1366.

https://doi.org/10.1182/bloodadvances.2019000980

Published: 2020

Includes: Supplemental data

Journal Articles

von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome

Alice Taylor, Chiara Vendramin, Deepak Singh, Martin M. Brown, Marie Scully

Blood Adv (2020) 4 (2): 398–407.

https://doi.org/10.1182/bloodadvances.2019000979

Published: 2020

Includes: Supplemental data

Journal Articles

Circulating CD1c + myeloid dendritic cells are potential precursors to LCH lesion CD1a + CD207 + cells

Blood Adv (2020) 4 (1): 87–99.

https://doi.org/10.1182/bloodadvances.2019000488

Published: 2020

Includes: Supplemental data

NARROW

Single- and double-hit events in genes encoding immune targets before and after T cell–engaging antibody therapy in MM

Preclinical evaluation of immunotherapeutic regimens for fetal/neonatal alloimmune thrombocytopenia

Effective anti-BCMA retreatment in multiple myeloma

Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions

Teclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma

A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data

Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant

von Willebrand factor variant D1472H has no effect in mice with humanized VWF-platelet interactions

Predictive modeling of complex ABO glycan phenotypes by lectin microarrays

Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease

Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies

Development and validation of a universal blood donor genotyping platform: a multinational prospective study

Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D′D3 and D4 domains

Low VWF: insights into pathogenesis, diagnosis, and clinical management

CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma

Passively transferred IgG enhances humoral immunity to a red blood cell alloantigen in mice

Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial

Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire

von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome

Circulating CD1c + myeloid dendritic cells are potential precursors to LCH lesion CD1a + CD207 + cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only